TY - JOUR
T1 - Acute generalized exanthematous pustulosis associated with polysensitivity to paracetamol and bromhexine
T2 - The diagnostic role of in vitro interferon-γ release test
AU - Halevy, S.
AU - Cohen, A. D.
AU - Livni, E.
PY - 2000/12/1
Y1 - 2000/12/1
N2 - We report a patient with acute generalized exanthematous pustulosis (AGEP), which occurred 3 days after ingesting paracetamol and bromhexine. Both were immediately stopped and the rash resolved rapidly. To determine the offending drug responsible for AGEP, an in vitro drug-induced interferon (IFN)-γ release test was performed using an ELISA technique. Increased IFN-γ release was observed following in vitro challenge of the patient's lymphocytes with paracetamol or bromhexine (110% and 157% increase, respectively). In vitro challenge with paracetamol or bromhexine in a control patient, treated with paracetamol and bromhexine, did not induce an increase in IFN-γ. These findings suggest that the patient with AGEP may have polysensitivity to both drugs. The ELISA assessment also demonstrates the relevance of in vitro cytokine release tests in the investigation of such dermatoses.
AB - We report a patient with acute generalized exanthematous pustulosis (AGEP), which occurred 3 days after ingesting paracetamol and bromhexine. Both were immediately stopped and the rash resolved rapidly. To determine the offending drug responsible for AGEP, an in vitro drug-induced interferon (IFN)-γ release test was performed using an ELISA technique. Increased IFN-γ release was observed following in vitro challenge of the patient's lymphocytes with paracetamol or bromhexine (110% and 157% increase, respectively). In vitro challenge with paracetamol or bromhexine in a control patient, treated with paracetamol and bromhexine, did not induce an increase in IFN-γ. These findings suggest that the patient with AGEP may have polysensitivity to both drugs. The ELISA assessment also demonstrates the relevance of in vitro cytokine release tests in the investigation of such dermatoses.
UR - http://www.scopus.com/inward/record.url?scp=0034493681&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2230.2000.00729.x
DO - 10.1046/j.1365-2230.2000.00729.x
M3 - Article
C2 - 11167983
AN - SCOPUS:0034493681
SN - 0307-6938
VL - 25
SP - 652
EP - 654
JO - Clinical and Experimental Dermatology
JF - Clinical and Experimental Dermatology
IS - 8
ER -